ACTBL2

ACTBL2 (kappa-actin) is a polymerization-competent actin isoform that controls cytoskeletal dynamics underlying cell motility and invasion (PMID:33558623). It forms complexes with the actin-severing protein gelsolin in both cytoplasmic and nuclear compartments, aligns with stress fibers, and redistributes into lamellipodia, with loss-of-function altering invasion, focal adhesion formation, actin polymerization, and migration (PMID:33558623, PMID:26598132). Its expression is transcriptionally driven by the osmosensitive/mechanosensitive transcription factor TonEBP/NFAT5, which translocates to the nucleus under biomechanical stretch and binds the ACTBL2 promoter; this NFAT5→ACTBL2 axis governs migration in vascular smooth muscle and ovarian cancer cells (PMID:25520667, PMID:34631538). Beyond its cytoskeletal role, ACTBL2 functions in NF-κB signaling by competing with the E3 ligase RBCK1 for binding to MTSS1, thereby blocking RBCK1-mediated ubiquitination and degradation of the NF-κB subunit p65 and stabilizing NF-κB activity (PMID:35122005).

1. 2014 Medium

   Established how ACTBL2 expression is controlled, identifying NFAT5 as a direct mechanosensitive transcriptional driver and linking ACTBL2 to stretch-responsive cytoskeletal remodeling.

   Evidence Immunofluorescence, Western blot, in silico promoter analysis, NFAT5 siRNA knockdown, and migration assays in vascular smooth muscle cells

   PMID:25520667

   Open questions at the time

   • Direct NFAT5 occupancy of the ACTBL2 promoter shown by in silico analysis rather than ChIP
   • Mechanism linking ACTBL2 to lamellipodia redistribution under stretch not resolved
2. 2015 Medium

   Identified a direct physical partner for ACTBL2, showing it complexes with the actin-regulatory protein gelsolin in distinct subcellular compartments.

   Evidence Reciprocal Co-IP with mass spectrometry, confirmed by PLA and confocal microscopy in melanoma cells

   PMID:26598132

   Open questions at the time

   • Functional consequence of the gelsolin interaction not defined
   • Significance of separate nuclear vs cytoplasmic pools unclear
3. 2020 High

   Revealed a non-cytoskeletal signaling role, showing ACTBL2 stabilizes NF-κB p65 by competing with RBCK1 for MTSS1, thereby blocking p65 ubiquitination.

   Evidence Reciprocal Co-IP competition and ubiquitination assays plus genetic perturbation in breast cancer cell lines and mouse models

   PMID:35122005

   Open questions at the time

   • Whether actin polymerization activity is required for the MTSS1/RBCK1 competition is unknown
   • Structural basis of competitive binding not determined
4. 2021 Medium

   Defined ACTBL2 as the seventh actin isoform with an essential role in motility, demonstrating that its loss or overexpression remodels actin-dependent structures and invasion.

   Evidence CRISPR knockout and overexpression with invasion, focal adhesion, polymerization, lamellipodia, and stress fiber assays in melanoma cell lines

   PMID:33558623

   Open questions at the time

   • Single-lab phenotyping
   • Atomic structure and copolymerization behavior with canonical actins not established
5. 2021 Medium

   Generalized the NFAT5→ACTBL2 axis beyond vascular cells, showing it supports viability, proliferation, and migration in epithelial ovarian cancer.

   Evidence siRNA knockdown of ACTBL2 and NFAT5 with viability, proliferation, and migration assays in EOC cell lines

   PMID:34631538

   Open questions at the time

   • Mechanism linking ACTBL2 to proliferation versus migration not separated
   • No in vivo confirmation in ovarian cancer

• How ACTBL2's cytoskeletal/actin-polymerization function mechanistically connects to its role in NF-κB signaling, and whether it copolymerizes with canonical actins in cells, remains unresolved.
• No structural model of ACTBL2 filaments or interaction interfaces
• Tissue-level physiological function not established